Current Bioinformatics
Title:Meet Our Editorial Board Member
Volume: 11 Issue: 2
Author(s): Ren Zhang
Affiliation:
Export Options
About this article
Cite this article as:
Zhang Ren, Meet Our Editorial Board Member, Current Bioinformatics 2016; 11 (2) . https://dx.doi.org/10.2174/157489361102160401164311
DOI https://dx.doi.org/10.2174/157489361102160401164311 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
23
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pharmacological Applications of Lignins and Lignins Related Compounds: An Overview
Current Organic Chemistry Natural Products Derived from the Mediterranean Diet with Antidiabetic Activity: from Insulin Mimetic Hypoglycemic to Nutriepigenetic Modulator Compounds
Current Pharmaceutical Design Angiotensin II-Induced Signaling Pathways in Diabetes
Current Diabetes Reviews The Role of Matrix Metalloproteinases in Essential Hypertension
Current Topics in Medicinal Chemistry Editorial (Thematic Issue: Linkage of Neurodegenerative Disorders with Other Health Issues – Volume II)
CNS & Neurological Disorders - Drug Targets Epidemiological Aspects of Seasonal and Pandemic Influenza in Recent Years and Emerging Viruses
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) Phytosterols: Perspectives in Human Nutrition and Clinical Therapy
Current Medicinal Chemistry Silymarin Extends Lifespan and Reduces Proteotoxicity in C. elegans Alzheimer’s Model
CNS & Neurological Disorders - Drug Targets Statins as Anti-Inflammatory Agents in Atherogenesis: Molecular Mechanisms and Lessons from the Recent Clinical Trials
Current Pharmaceutical Design The Pharmacological Treatment of Cachexia
Current Drug Targets Tailoring Particle Microstructures via Supercritical CO<sub>2</sub> Processes for Particular Drug Delivery
Current Pharmaceutical Design Bedtime Hypertension Chronotherapy: Concepts and Patient Outcomes
Current Pharmaceutical Design The Impact of Asymmetric Dimethylarginine (ADAMA), the Endogenous Nitric Oxide (NO) Synthase Inhibitor, to the Pathogenesis of Gastric Mucosal Damage
Current Pharmaceutical Design GPCR Drug Discovery: Novel Ligands for CNS Receptors
Recent Patents on CNS Drug Discovery (Discontinued) Insulin Resistance in the HIV-Infected Population: The Potential Role of Mitochondrial Dysfunction
Current Drug Targets - Infectious Disorders Editorial [Hot Topic: Nongenomic Effects of Thyroid Hormones in Central Nervous System and Skeletal Muscle (Guest Editor: Sandra Incerpi)]
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Sol-gel Derived Warfarin – Silica Composites for Controlled Drug Release
Current Drug Delivery The Prothrombotic State in Hypertension and the Effects of Antihypertensive Treatment
Current Pharmaceutical Design Identifying the Metabolic Syndrome in Obese Children and Adolescents: Do Age and Definition Matter?
Current Clinical Pharmacology Ribosome Inactivating Proteins (RIPs) from Momordica charantia for Anti Viral Therapy
Current Molecular Medicine